Pepperrell Toby, Hill Andrew, Cross Samuel
School of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
NHS Greater Glasgow and Clyde, NHS Scotland, Glasgow, UK.
Open Forum Infect Dis. 2024 Jun 6;11(7):ofae318. doi: 10.1093/ofid/ofae318. eCollection 2024 Jul.
The United Nations Program on HIV/AIDS (UNAIDS) targets aim to reduce new HIV infections below 370 000 annually by 2025. However, there were 1.3 million new HIV infections worldwide in 2022. We collected and analyzed data for key variables of the HIV epidemic from UNAIDS and supplemented by PUBMED/EMBASE searches and national reports. A total of 53% of the HIV infections worldwide were in 14 high-prevalence countries in Southern/East Africa-where most of the funding for treatment and prevention is allocated-versus 47% in 54 low-prevalence countries. In 2022, there were more new HIV infections (770 000 vs 468 000), more HIV-related deaths (383 000 vs 225 000), higher rates of mother-to-child transmissions (16% vs 9%) and lower antiretroviral therapy coverage (67% vs 83%) in low-prevalence countries versus high-prevalence countries. To achieve UNAIDS annual new infections target for 2025, ART coverage needs to be optimized worldwide, and preexposure prophylaxis coverage expanded to 74 million people, versus 2.5 million currently treated.
联合国艾滋病规划署(UNAIDS)的目标是到2025年将每年新增的艾滋病毒感染人数降至37万以下。然而,2022年全球新增艾滋病毒感染人数为130万。我们收集并分析了来自UNAIDS的艾滋病毒疫情关键变量数据,并通过PUBMED/EMBASE检索和国家报告进行补充。全球53%的艾滋病毒感染发生在南部/东部非洲的14个高流行国家,这些国家分配了大部分治疗和预防资金,而54个低流行国家的感染率为47%。2022年,低流行国家与高流行国家相比,新增艾滋病毒感染人数更多(77万对46.8万),与艾滋病毒相关的死亡人数更多(38.3万对22.5万),母婴传播率更高(16%对9%),抗逆转录病毒疗法覆盖率更低(67%对83%)。为实现UNAIDS设定的2025年年度新增感染目标,需要在全球范围内优化抗逆转录病毒疗法的覆盖率,并将暴露前预防覆盖率扩大到7400万人,而目前接受治疗的人数为250万。